Odonate down after $150M IPO

Odonate Therapeutics Inc. (NASDAQ:ODT) closed the week down at $22.67 after it raised $150 million late Wednesday through the sale of 6.3 million shares at $24 in an IPO underwritten by Goldman Sachs, Jefferies and Cowen. The IPO price values the company at $645.4 million.

The company filed in November to raise up to $182.6 million through the sale of 6.8 million shares at $24-$27. At the $25.50 midpoint, a sale of that many shares would have raised $172.4 million...